Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases
- PMID: 21565895
- PMCID: PMC3932662
- DOI: 10.1258/ebm.2011.010389
Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases
Abstract
Chemokines and their receptors are implicated in a wide range of human diseases, including acquired immune deficiency syndrome (AIDS). The entry of human immunodeficiency virus type 1 (HIV-1) into a cell is initiated by the interaction of the virus's surface envelope proteins with two cell surface components of the target cell, namely CD4 and a chemokine co-receptor, usually CXCR4 or CCR5. Typical anti-HIV-1 agents include protease and reverse transcriptase inhibitors, but the targets of these agents tend to show rapid mutation rates. As such, strategies based on HIV-1 co-receptors have appeal because they target invariant host determinants. Chemokines and their receptors are also of general interest since they play important roles in numerous physiological and pathological processes in addition to AIDS. Therefore, intensive basic and translational research is ongoing for the dissection of their structure - function relationships in an effort to understand the molecular mechanism of chemokine - receptor interactions and signal transductions across cellular membranes. This paper reviews and discusses recent advances and the translation of new knowledge and discoveries into novel interventional strategies for clinical application.
Similar articles
-
gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.J Neurochem. 2000 Jun;74(6):2373-9. doi: 10.1046/j.1471-4159.2000.0742373.x. J Neurochem. 2000. PMID: 10820198
-
A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R.Blood. 1999 Aug 15;94(4):1165-73. Blood. 1999. PMID: 10438703
-
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.Nat Med. 1997 Nov;3(11):1259-65. doi: 10.1038/nm1197-1259. Nat Med. 1997. PMID: 9359702
-
HIV-1 infection and chemokine receptor modulation.Curr HIV Res. 2004 Jan;2(1):39-50. doi: 10.2174/1570162043484997. Curr HIV Res. 2004. PMID: 15053339 Review.
-
[Deep lung--cellular reaction to HIV].Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Rev Port Pneumol. 2007. PMID: 17492233 Review. Portuguese.
Cited by
-
High affinity CXCR4 inhibitors generated by linking low affinity peptides.Eur J Med Chem. 2019 Jun 15;172:174-185. doi: 10.1016/j.ejmech.2019.03.056. Epub 2019 Apr 1. Eur J Med Chem. 2019. PMID: 30978562 Free PMC article.
-
Lack of RNase L attenuates macrophage functions.PLoS One. 2013 Dec 4;8(12):e81269. doi: 10.1371/journal.pone.0081269. eCollection 2013. PLoS One. 2013. PMID: 24324683 Free PMC article.
-
Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents.Int J Mol Sci. 2015 Jun 8;16(6):12958-85. doi: 10.3390/ijms160612958. Int J Mol Sci. 2015. PMID: 26062132 Free PMC article. Review.
-
The molecular mechanism of hypertrophic scar.J Cell Commun Signal. 2013 Dec;7(4):239-52. doi: 10.1007/s12079-013-0195-5. Epub 2013 Mar 18. J Cell Commun Signal. 2013. PMID: 23504443 Free PMC article.
-
HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA.PLoS One. 2015 Sep 28;10(9):e0139037. doi: 10.1371/journal.pone.0139037. eCollection 2015. PLoS One. 2015. PMID: 26413773 Free PMC article.
References
-
- Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. Nat Med. 1996;2:1174–8. - PubMed
-
- Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol. 1994;12:593–633. - PubMed
-
- Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657–700. - PubMed
-
- Fernandez EJ, Lolis E. Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol. 2002;42:469–99. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials